Reported Aug 17, 2022 · Terminated
Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured by West-Ward Eatontown, NJ…
Hikma Pharmaceuticals USA Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Hikma Pharmaceuticals USA Inc. · 2 Esterbrook Ln · Cherry Hill, NJ · 08003-4002
Is this the product you have?
Lorazepam InjectionUSP2mg/mL1 mL vial25 vials per cartonRX OnlyManufactured by West-Ward EatontownNJ 07724Carton NDC# 0641-6044-25Vial NDC# 0641-6044-01
- Lot codes and dates
Lot # 060064Exp. 06/2023070084Exp. 07/2023070126Exp. 07/2023080091Exp. 08/2023080060Exp. 08/2023
- Amount recalled
- 4,739,000 vials
This recall covers 4 products
The agency filed one notice per product. You are reading one of them; the other 3 are below.
Where it was sold
- Nationwide
Why it was recalled
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Hikma Pharmaceuticals USA Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.